Several companies have announced new executives and board members appointments as they prepare for growth in 2025.

Eyebright Medical's Loong Crystal PR IOL received Class III certification from China's NMPA, indicating high regulatory ...

Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss deep learning systems and whether they can distinguish between optic disc drusen and true papilledema ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The application was refiled following a December 20, 2024, meeting between the US Food and Drug Administration and Astellas.

ViGeneron GmbH, a clinical-stage gene therapy company based in Munich, Germany, shared details of two new milestones in an ...

The Epithelial Thickness Module is expected to be commercially available in February 2025. According to Heidelberg ...

These resources include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, ...

Himani Goyal, MD, discusses a complex glaucoma case involving persistent intraocular pressure elevation despite multiple treatment procedures, focusing on advanced management strategies and ...

The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise ...

Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...